Histogen and Replicel : stem cell meeting on the Mesa
Collapse
X
-
actually accroding to hailoss cure 2020 site the trials will be 1 year long. and in the presentation summary their Primary commercial endpoint is efficacy at 52 weeks after final injection. which mean that some data will be obtained from the patients (Group 1) that will receive only one injection of a higher dose. -
seems like all we are getting is delays. but if shieshido took advantage of the regenerative medicine law, they still could commercialize the product before finishing the trials.
anything on histogen?Leave a comment:
-
Leave a comment:
-
Leave a comment:
-
But Shiseido was delayed for first half 2015... Not sure what they are waiting on. They have the money and the facilities. I noticed in the presentation they have TBD for the Japan trails instead of phase numbers. Not sure what that means.Leave a comment:
-
-
Replicel said theyre still on track for starting phase 2 this year. Unfortunately the trial will last two years >.>Leave a comment:
-
According to the website, they're gonna be streaming the presentations! I know I'll be listening instead of working. http://stemcellmeetingonthemesa.com/webcast./Leave a comment:
-
Good stuff but I'm not optimistic about Histogen being able to commercialise HSC.Leave a comment:

Leave a comment: